lithium carbonate has been researched along with Alzheimer Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guttuso, T | 1 |
| Borlongan, CV; Currier, G; Habib, A; Hou, H; Koilraj, S; Munna, SA; Rongo, D; Sawmiller, D; Shytle, RD; Tan, J | 1 |
| Albuquerque, MS; Balthazar, J; Baraldi-Tornisielo, T; Buck, HS; Caetano, AL; Monteiro-Silva, KC; Nunes, MA; Schöwe, NM; Souza, SI; Viel, TA | 1 |
| Pomara, N | 1 |
| Reiman, EM | 1 |
| Aisen, PS; Tariot, PN | 1 |
| Annas, P; Basun, H; Bogstedt, A; Bürger, K; Ewers, M; Frölich, L; Gasser, T; Hampel, H; Kraft, I; Kurz, A; Leyhe, T; Möller, HJ; Mörtberg, A; Riepe, MW; Schönknecht, P; Schröder, J | 1 |
| Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J | 1 |
| Banay-Schwartz, M; Block, R; Gershon, S; Pomara, N; Stanley, M | 1 |
| Barnett, N; Block, R; Brinkman, SD; Domino, EF; Gershon, S; Pomara, N | 1 |
| Block, R; Domino, EF; Gershon, S; Pomara, N | 1 |
| Gershon, S; Kelwala, S; Pomara, N; Sitaram, N; Stanley, M | 1 |
| Ford, DI; Marco, LA; Mitchell, R; Plesnarski, J; Randels, PM; Scholl, M | 1 |
| Gastpar, M; Jüptner, M; Paulus, HJ | 1 |
| Barnes, R; Risse, SC | 1 |
3 review(s) available for lithium carbonate and Alzheimer Disease
| Article | Year |
|---|---|
High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
Topics: alpha-Synuclein; Alzheimer Disease; Autophagy; beta Catenin; beta-Glucosidase; Brain Chemistry; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Incidence; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lithium; Lithium Carbonate; Melanoma; Models, Biological; Mutation; Neuroprotective Agents; Nicotiana; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Parkinsonian Disorders; Smokers; Water; Wnt Signaling Pathway | 2019 |
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2010 |
Pharmacologic treatment of agitation associated with dementia.
Topics: Affective Symptoms; Aged; Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dementia; Humans; Lithium; Lithium Carbonate; Propranolol; Psychotropic Drugs | 1986 |
2 trial(s) available for lithium carbonate and Alzheimer Disease
| Article | Year |
|---|---|
Lithium treatment in Alzheimer's disease does not promote cognitive enhancement, but may exert long-term neuroprotective effects.
Topics: Alzheimer Disease; Antimanic Agents; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Lithium Carbonate; Memory, Short-Term; Neurons; Neuropsychological Tests; Single-Blind Method | 2009 |
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Enzyme Inhibitors; Female; Glycogen Synthase Kinase 3; Humans; Lithium Carbonate; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Peptide Fragments; Phosphorylation; Psychometrics; Single-Blind Method; tau Proteins | 2009 |
10 other study(ies) available for lithium carbonate and Alzheimer Disease
| Article | Year |
|---|---|
Comparing the effect of the novel ionic cocrystal of lithium salicylate proline (LISPRO) with lithium carbonate and lithium salicylate on memory and behavior in female APPswe/PS1dE9 Alzheimer's mice.
Topics: Alzheimer Disease; Animals; Behavior; Body Weight; Conditioning, Psychological; Fear; Female; Hindlimb Suspension; Lithium Carbonate; Lithium Compounds; Locomotion; Maze Learning; Memory; Mice; Mice, Transgenic; Motor Activity; Proline; Salicylates; Spatial Memory | 2019 |
Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
Topics: Administration, Oral; Alzheimer Disease; Amnesia; Animals; Avoidance Learning; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; Gene Expression; Hippocampus; Humans; Lithium Carbonate; Locomotion; Male; Maze Learning; Memory; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid | 2015 |
Untangling the roles of antidepressants and mood stabilizers in the treatment of Alzheimer's disease. Introduction.
Topics: Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Dose-Response Relationship, Drug; Humans; Irritable Mood; Lithium Carbonate; Motivation; Selective Serotonin Reuptake Inhibitors | 2009 |
Can lithium or valproate untie tangles in Alzheimer's disease?
Topics: Aged; Alzheimer Disease; Anticonvulsants; Brain; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Lithium Carbonate; Neurofibrillary Tangles; Phosphorylation; Plaque, Amyloid; Randomized Controlled Trials as Topic; tau Proteins; Valproic Acid | 2009 |
Elevation of RBC glycine and choline levels in geriatric patients treated with lithium.
Topics: Aged; Alzheimer Disease; Choline; Cognition Disorders; Dementia; Erythrocytes; Female; Glycine; Humans; Lithium; Lithium Carbonate; Male | 1983 |
Lithium-induced increases in red blood cell choline and memory performance in Alzheimer-type dementia.
Topics: Aged; Alzheimer Disease; Choline; Erythrocytes; Humans; Lithium; Lithium Carbonate; Memory; Middle Aged | 1984 |
Decay in plasma lithium and normalization in red blood cell choline following cessation of lithium treatment in two elderly individuals with Alzheimer-type dementia.
Topics: Aged; Alzheimer Disease; Choline; Erythrocytes; Humans; Lithium; Lithium Carbonate; Male; Substance Withdrawal Syndrome | 1984 |
Lithium-induced accentuation of extrapyramidal symptoms in individuals with Alzheimer's disease.
Topics: Acute Disease; Aged; Alzheimer Disease; Basal Ganglia Diseases; Erythrocytes; Female; Humans; Lithium; Lithium Carbonate; Male; Middle Aged | 1984 |
Lithium and lecithin treatment in Alzheimer's disease: a pilot study.
Topics: Aged; Alzheimer Disease; Basal Ganglia Diseases; Cognition; Drug Therapy, Combination; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Phosphatidylcholines; Pilot Projects | 1984 |
[Delusional depression as differential dementia of the Alzheimer type diagnosis].
Topics: Aged; Alzheimer Disease; Combined Modality Therapy; Delusions; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium Carbonate; Male; Trimipramine | 2002 |